Epidemiologic Characteristics and Natural History of HIV-1 Natural Viral Suppressors

被引:58
作者
Sajadi, Mohammad M. [1 ]
Constantine, Neil T. [1 ]
Mann, Dean L. [2 ]
Charurat, Manhattan [1 ]
Dadzan, Elham [1 ]
Kadlecik, Peter [3 ]
Redfield, Robert R. [1 ]
机构
[1] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
[3] Chase Brexton Hlth Serv, Baltimore, MD USA
关键词
elite suppressor; elite controller; HIV; natural viral suppressor; natural history; LONG-TERM NONPROGRESSORS; IMMUNODEFICIENCY-VIRUS TYPE-1; ELITE SUPPRESSORS; DISEASE PROGRESSION; IN-VITRO; REPLICATION; INFECTION; SURVIVORS; THERAPY; EXPRESSION;
D O I
10.1097/QAI.0b013e3181945f1e
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: The objective of this study was to detail the epidemiologic characteristics and natural history of HIV-1 natural viral suppressors (NVSs), a cohort of HIV-1-infiected individuals who are able to suppress viral replication to undetectable levels in the absence of therapy. Design and Methods: HIV-1 patients who met the NVS criteria were enrolled into a prospective study. The incidence and prevalence of NVS were calculated by performing a chart review on all patients seen in 1 clinic in a 10-year period. Cumulative probability of progression-free survival was calculated by Kaplan-Meier product limit method. Results: Forty individuals enrolled in the study. The median year of diagnosis was 1994, and individuals demonstrated a median 6.7 years of HIV-1 viral suppression and CD4 count of 795 cells per microliter. NVS had an incidence of 1.1% [95% confidence interval (CI), 0.0 to 2.1] and prevalence of 1.5% (95% CI, 0.8 to 2.1). Only 1 patient (2.5%) has progressed. Within the first 10 years for follow-up having met the definition of NVS, 95.1% (95% CI 86.5% to 100%) of the NVS continued to control their viral loads to undetectable levels. Conclusions: The NVS cohort has demonstrated remarkable stability and a low rate of progression over many years. Detailed evaluations of viral-host immune regulatory factors associated with persistent HIV-1 natural viral suppression, and loss of such suppression, has the potential to provide important new insight in HIV pathogenesis and future immune regulatory targeted preventive and therapeutic research.
引用
收藏
页码:403 / 408
页数:6
相关论文
共 23 条
[11]   The role of protective HCPS and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors [J].
Han, Yefei ;
Lai, Jun ;
Barditch-Crovo, Patricia ;
Gallant, Joel E. ;
Williams, Thomas M. ;
Siliciano, Robert F. ;
Blankson, Joel N. .
AIDS, 2008, 22 (04) :541-544
[12]  
KLOOSTERBOER N, 2005, VIROLOGY, V15, P339
[13]   HIV controllers: A homogeneous group of HIV-1-infected patients with spontaneous control of viral replication [J].
Lambotte, O ;
Boufassa, F ;
Madec, Y ;
Nguyen, A ;
Goujard, C ;
Meyer, L ;
Rouzioux, C ;
Venet, A ;
Delfraissy, JF .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (07) :1053-1056
[14]  
MANN DL, 1996, SCIENCE, V273, P1856
[15]   HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors [J].
Migueles, SA ;
Sabbaghian, MS ;
Shupert, WL ;
Bettinotti, MP ;
Marincola, FM ;
Martino, L ;
Hallahan, CW ;
Selig, SM ;
Schwartz, D ;
Sullivan, J ;
Connors, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2709-2714
[16]   Biased G-to-A hypermutation in HIV-1 proviral DNA from a long-term non-progressor [J].
Min, W ;
Hui, X ;
Hong, KX ;
Huang, HL ;
Tang, HL ;
Qin, GM ;
Shao, YM .
AIDS, 2004, 18 (13) :1863-1865
[17]   HLA gene and haplotype frequencies in the North American population - The National Marrow Donor Program Donor Registry [J].
Mori, M ;
Beatty, PG ;
Graves, M ;
Boucher, KM ;
Milford, EL .
TRANSPLANTATION, 1997, 64 (07) :1017-1027
[18]   STUDIES IN SUBJECTS WITH LONG-TERM NONPROGRESSIVE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
PANTALEO, G ;
MENZO, S ;
VACCAREZZA, M ;
GRAZIOSI, C ;
COHEN, OJ ;
DEMAREST, JF ;
MONTEFIORI, D ;
ORENSTEIN, JM ;
FOX, C ;
SCHRAGER, LK ;
MARGOLICK, JB ;
BUCHBINDER, S ;
GIORGI, JV ;
FAUCI, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :209-216
[19]   Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy [J].
Pereyra, Florencia ;
Addo, Marylyn M. ;
Kaufmann, Daniel E. ;
Liu, Yang ;
Miura, Toshiyuki ;
Rathod, Almas ;
Baker, Brett ;
Trocha, Alicja ;
Rosenberg, Rachel ;
Mackey, Elizabeth ;
Ueda, Peggy ;
Lu, Zhigang ;
Cohen, Daniel ;
Wrin, Terri ;
Petropoulos, Christos J. ;
Rosenberg, Eric S. ;
Walker, Bruce D. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (04) :563-571
[20]  
Rodés B, 2004, AIDS, V18, P1109, DOI [10.1097/01.aids.0000125962.16506.f9, 10.1097/00002030-200405210-00004]